Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

South Korea flag South Korea · Delayed Price · Currency is KRW
242,500
+3,500 (1.46%)
Jun 9, 2026, 3:30 PM KST
Market Cap5.64T +63.9%
Revenue (ttm)246.05B +15.5%
Net Income10.23B
EPS437.07
Shares Out 23.26M
PE Ratio551.21
Forward PEn/a
Dividend200.00 (0.08%)
Ex-Dividend DateDec 29, 2025
Volume331,119
Open238,000
Previous Close239,000
Day's Range229,000 - 252,500
52-Week Range140,000 - 1,233,000
Beta1.26
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Sam Chun Dang Pharm.

Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, S... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1943
Employees 422
Stock Exchange KOSDAQ
Ticker Symbol 000250
Full Company Profile

Financial Performance

Financial Statements